Instil Bio, Inc. (TIL) Form 10-Q Quarterly Reports
Instil Bio, Inc. (TIL) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TIL
CIK: 1789769
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: NY
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerElijah Rinn
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001789769-26-000057 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001789769-26-000055 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | FORM 4 | 0001402856-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | FORM 4 | 0001851336-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | FORM 4 | 0001555918-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | FORM 4 | 0001791742-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-11 | 8-K | 0001789769-26-000048 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001789769-26-000045 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-15 | 8-K | 0001789769-26-000044 | View SEC Doc Filr Page |
| ARS | 2026-04-24 | 2025-12-31 | ARS | 0001789769-26-000034 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-24 | — | DEFA14A | 0001789769-26-000032 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-24 | 2026-06-11 | DEF 14A | 0001789769-26-000030 | View SEC Doc Filr Page |
| 8-K | 2026-04-03 | 2026-04-01 | 8-K | 0001789769-26-000024 | View SEC Doc Filr Page |
| S-8 | 2026-03-27 | — | S-8 | 0001193125-26-127624 | View SEC Doc Filr Page |
| 10-K | 2026-03-27 | 2025-12-31 | 10-K | 0001789769-26-000019 | View SEC Doc Filr Page |
| 8-K | 2026-03-27 | 2026-03-27 | 8-K | 0001789769-26-000018 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-09 | — | SCHEDULE 13G/A Filing | 0001373604-26-000016 | View SEC Doc Filr Page |
| 8-K | 2026-01-06 | 2026-01-05 | 8-K | 0001789769-26-000004 | View SEC Doc Filr Page |
| 10-Q | 2025-11-13 | 2025-09-30 | 10-Q | 0001789769-25-000094 | View SEC Doc Filr Page |
| 8-K | 2025-11-13 | 2025-11-13 | 8-K | 0001789769-25-000092 | View SEC Doc Filr Page |
| 4 | 2025-09-12 | 2025-09-10 | FORM 4 | 0001789769-25-000087 | View SEC Doc Filr Page |
| 144 | 2025-09-10 | — | 144 Filing | 0001950047-25-006960 | View SEC Doc Filr Page |
| 10-Q | 2025-08-13 | 2025-06-30 | 10-Q | 0001789769-25-000081 | View SEC Doc Filr Page |
| 8-K | 2025-08-13 | 2025-08-13 | 8-K | 0001789769-25-000079 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-08-12 | — | SCHEDULE 13G/A Filing | 0001213900-25-075187 | View SEC Doc Filr Page |